Mori H, Itoh N, Tamaya T
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Immunopharmacol Immunotoxicol. 1989;11(1):33-53. doi: 10.3109/08923978909082141.
In four ovarian cancer patients with malignant ascites, 10 KE of OK-432 was intraperitoneally administered four times every other day for priming, and 40 KE of OK-432 in a single dose by the same route on day 13 for triggering. The changes in peripheral blood monocytes and intraperitoneal macrophages and the production of tumor necrosis factor (TNF) by peripheral blood mononuclear cells (PBMC) and ascitic lymphoid cells (ALC) were examined. In two of the four patients in whom TNF was induced in the ascites, the TNF production by PBMC and ALC was noted during priming, and after triggering, an increase in both the number of intraperitoneal macrophages and the TNF production by ALC was noted. In two other patients in whom TNF was not detected in the ascites, the ratio of intraperitoneal macrophages to ALC did not change throughout the whole period, and the TNF production by ALC was not augmented. These findings suggest that the priming administration of OK-432 can induce both intraperitoneal macrophages and peripheral blood monocytes into a primed state, and the triggering administration of OK-432 can increase the number of intraperitoneal OK-432-primed macrophages and induce TNF release from these cells.
在4例伴有恶性腹水的卵巢癌患者中,每隔一天腹腔注射10KE的溶链菌制剂(OK-432)4次进行预刺激,在第13天通过相同途径单次注射40KE的OK-432进行激发。检测外周血单核细胞和腹腔巨噬细胞的变化,以及外周血单个核细胞(PBMC)和腹水淋巴细胞(ALC)产生肿瘤坏死因子(TNF)的情况。在4例腹水中诱导出TNF的患者中的2例,在预刺激期间观察到PBMC和ALC产生TNF,激发后,观察到腹腔巨噬细胞数量和ALC产生TNF均增加。在另外2例腹水中未检测到TNF的患者中,整个期间腹腔巨噬细胞与ALC的比例未发生变化,且ALC产生TNF未增加。这些发现表明,OK-432的预刺激给药可使腹腔巨噬细胞和外周血单核细胞均进入预刺激状态,而OK-432的激发给药可增加腹腔中经OK-432预刺激的巨噬细胞数量,并诱导这些细胞释放TNF。